The DOI matches its Crossref record.
Elevation of Certain Plasma Proteins in Man Following Estrogen Administration: A Dose-Response Relationship
Abstract
The degree of elevation of the plasma concentrations of corticosteroid-binding globulin (CBG), β-glucuronidase and ceruloplasmin in response to estrogen administration was shown to be related, within limits, to the dose of estrogen. Three estrogenic materials—Premarin, diethylstilbestrol and ethinylestradiol—were tested. The highest dose-response correlation was observed with CBG and the lowest with ceruloplasmin. Ratios of potency for Premarin, diethylstilbestrol and ethinylestradiol were found to be 1:13–15:100–400, respectively. Women were found to show a significantly greater CBG rise than men after 7 days of 5 mg of diethylstilbestrol. The maximal rise of plasma CBG was found after 14 days of 5 mg of diethylstilbestrol daily. The response in 7 days was 67% of maximum.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, as the estrogen dose varies between different COC formulations, a common cutoff could be unreliable due to a different degree of CBG induction (6).”
From Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test (2024) · cites this paper as [6]
In the citing paper
“However, an increased amount of corticosteroid-binding globulin (CBG) entails a risk for misleadingly normal total plasma cortisol levels as more CBG-bound cortisol will be measured, even though cortisol release and free, biologically active cortisol levels may be low (5-9).”
From Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test (2024) · cites this paper as [6]
In the citing paper
“CBG induction has been reported to be dependent on the estrogen dose and not to be influenced by the synthetic progestin component of the COC (6, 18).”
From Salivary Cortisol and Cortisone Can Circumvent Confounding Effects of Oral Contraceptives in the Short Synacthen Test (2024) · cites this paper as [6]
Citations
Cited by
Sorted by citations
Cooke, P. S., Nanjappa, M. K., Ko, C. J., Prins, G. S., & Hess, R. A. (2017) · Physiological Reviews · doi:10.1152/physrev.00018.2016 · Cited by 489
Pathology of the Human Placenta
Benirschke, K., & Kaufmann, P. (2000) · Springer eBooks · doi:10.1007/978-1-4757-4199-5 · Cited by 400
Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes.
Yaneva, M., Mosnier-Pudar, H., Dugué, M.-A., Grabar, S., Fulla, Y., & Bertagna, X. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031790 · Cited by 179
Regulation of cortisol bioavailability—effects on hormone measurement and action
Perogamvros, I., Ray, D. W., & Trainer, P. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.134 · Cited by 167
Bailar, J. C., & Byar, D. P. (1970) · Cancer · doi:10.1002/1097-0142(197008)26:2 · Cited by 244
Self-citationDevelopment of the HPA axis: Where and when do sex differences manifest?
Panagiotakopoulos, L., & Neigh, G. N. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.03.002 · Cited by 148
“Sex differences in glucocorticoid function are also influenced at the level of CBG. CBG is synthesized mainly in the liver, and estrogens increase its production (Musa et al., 1965; Brien, 1981).”
Diethylstilbestrol Usage: Its Interesting Past, Important Present, and Questionable Future
Noller, K. L., & Fish, C. R. (1974) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)32122-8 · Cited by 133
Acute Phase Reactant Proteins in Cancer
Cooper, E. H., & Stone, J. (1979) · Advances in cancer research · doi:10.1016/s0065-230x(08)60893-3 · Cited by 115
Song, C. S., Rifkind, A. B., GILLETTE, P. N., et al. (1969) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(69)90017-9 · Cited by 98
Serum protein concentrations in pregnancy
Mendenhall, H. W. (1970) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(70)90364-9 · Cited by 96
Corticosteroid-binding globulin: The clinical significance of altered levels and heritable mutations
Gagliardi, L., Ho, J. T., & Torpy, D. J. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.015 · Cited by 88
Estrogen Receptor in Adult Male Rat Liver*
Aten, R. F., Dickson, R. B., & Eisenfeld, A. J. (1978) · Endocrinology · doi:10.1210/endo-103-5-1629 · Cited by 85
Gervasio, J., Zheng, S., Skrotzki, C., & Pachete, A. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105626 · Cited by 79
Sinha, A. A., Blackard, C. E., & Seal, U. S. (1977) · Cancer · doi:10.1002/1097-0142(197712)40:6 · Cited by 69
Self-citationTreatment of Prostatic Carcinoma with Various Types of Estrogen Derivatives
Jönsson, G., Olsson, A. M., Luttrop, W., Čekan, Z., Purvis, K., & Diczfalusy, E. R. (1976) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60965-6 · Cited by 70
Corticosteroid-Binding Globulin: Biochemistry, Physiology, and Phylogeny
Seal, U. S., & DOE, R. P. (1966) · Elsevier eBooks · doi:10.1016/b978-1-4832-2903-4.50006-4 · Cited by 68
Self-citationAn in vivo system in man for quantitation of estrogenicity
Moore, D. E., Kawagoe, S., Davajan, V., Mishell, D. R., & Nakamura, R. M. (1978) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(78)90293-4 · Cited by 64
Bae, Y. J., & Kratzsch, J. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.09.001 · Cited by 67
An in vivo system in man for quantitation of estrogenicity
Moore, D. E., Kawagoe, S., Davajan, V., Nakamura, R. M., & Mishell, D. R. (1978) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(78)90294-6 · Cited by 57
On the use of Plasma Proteins as Indicators of the Metabolic Effects of Combined Oral Contraceptives
Cullberg, G., Dovré, P., Lindstedt, G., & Stéffensen, K. (1982) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348209155359 · Cited by 54
“It has been suggested that measurements of transcortin (13, 26, 28, 34), thyroxine binding globulin (22), serum copper or ceruloplasmin (1,7,22), SHBG (18, 25), and of pregnancy zone protein (12) can be used as indicators of the estrogenic potency of sexhormone active steroid combinations.”
BackgroundBuning, J. W., van Faassen, M. H. J. R., Brummelman, P., Dullaart, R. P. F., van den Berg, G., van der Klauw, M. M., Kerstens, M. N., Stegeman, C. A., Kobold, A. C. M., Kema, I. P., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2216 · Cited by 51
Determination of β‐Glucuronidases
Fishman, W. H. (1967) · Methods of biochemical analysis · doi:10.1002/9780470110331.ch3 · Cited by 50
Serum protein concentrations in pregnancy
Mendenhall, H. W. (1970) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(70)90044-x · Cited by 45
The Influence of Estrogens, Progestins, and Pregnancy on the Liver
Song, C. S., & Kappas, A. (1969) · Vitamins and hormones · doi:10.1016/s0083-6729(08)60754-2 · Cited by 43
Oral contraceptives and carbohydrate metabolism
Paola, G. D., Puchulu, F., Robin, M., Nicholson, R. F., & Marti, M. (1968) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(68)90189-0 · Cited by 42
Estrogen Replacement Therapy after the Menopause
Helgason, S. (1982) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348209155333 · Cited by 38
Effects of hormonal contraceptives and pregnancy on serum protein pattern
Gleichmann, W., Bachmann, G. W., Dengler, H. J., et al. (1973) · European Journal of Clinical Pharmacology · doi:10.1007/bf00567007 · Cited by 36
Oral contraceptive use by teenage women does not affect body composition
Lloyd, T. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02056-2 · Cited by 35
Oral contraceptives—possible mediation of side effects via an estrogen receptor in liver
Eisenfeld, A. J., Aten, R. F., & Weinberger, M. J. (1978) · Biochemical Pharmacology · doi:10.1016/0006-2952(78)90329-5 · Cited by 33
Brunner, E., Baima, J., Vieira, T. C., Vieira, J. G. H., & Abucham, J. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01783.x · Cited by 32
“…in plasma are increased during pregnancy, oestrogen therapy, contraceptives, as well as in patients with leukaemia (De Moor et al ., 1965; Musa et al ., 1965), and can be decreased by glucocorticoid administration (Schlechte & Hamilton, 1987), Cushing’s syndrome, cirrhosis, hypertension,…”
BackgroundEstrogenic Potency of Oral Replacement Therapy Estimated by the Induction of Pregnancy Zone Protein
Helgason, S., Damber, M. ‐., von Schoultz, B., & Stigbrand, T. I. (1982) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348209156956 · Cited by 31
Effect of oral contraceptives on serum protein concentrations
Mendenhall, H. W. (1970) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(70)90401-1 · Cited by 31
Increased serum cortisol binding in chronic active hepatitis
Orbach, O., & Schussler, G. C. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90227-1 · Cited by 29
Hormonal effects on the secretion and glycoform profile of corticosteroid-binding globulin
Mihrshahi, R., Lewis, J. G., & Ali, S. O. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.06.031 · Cited by 28
Graded sequential therapy in the menopause: A double-blind study
Martin, P. L., Burnier, A. M., Segre, E. J., et al. (1971) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(71)90887-8 · Cited by 28
THE FUNCTION OF THE ANTERIOR PITUITARY‐ADRENAL CORTEX AXIS IN HYPEREMESIS GRAVIDARUM
Kauppila, A., Ylikorkala, O., Järvinen, P. A., et al. (1976) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1976.tb00723.x · Cited by 26
Changes of Plasma Lipid Metabolism in Males during Estrogen Treatment for Prostatic Carcinoma*
Wallentin, L. C., & Varenhorst, E. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-47-3-596 · Cited by 26
Pharmacodynamic Studies on Desogestrel Administered Alone and in Combination with Ethinylestradiol
Cullberg, G. (1985) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348509157028 · Cited by 25
SERUM FSH, LH AND OESTRONE LEVELS IN POSTMENOPAUSAL PATIENTS ON OESTROGEN THERAPY
Larsson‐Cohn, U., Johansson, E. D. B., Kågedal, B., & Wallentin, L. C. (1978) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1978.tb14896.x · Cited by 24
Gulfo, J., Castel, R., Ledda, A., Romero, M. D. M., Esteve, M., & Grasa, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-50355-1 · Cited by 23
CORTISOL METABOLISM AFTER ORAL CONTRACEPTIVES: TOTAL PLASMA CORTISOL AND THE FREE CORTISOL INDEX
Brien, T. G. (1975) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1975.tb00609.x · Cited by 23
Using changes in binding globulins to assess oral contraceptive compliance
Westhoff, C. L., Petrie, K. A., & Cremers, S. (2013) · Contraception · doi:10.1016/j.contraception.2012.06.003 · Cited by 22
“The BGs studied here reach peak levels by about 14 days after starting daily OCP use and remain relatively constant thereafter [12, 18, 27, 28], dropping substantially as soon as five days after the last active OCP intake, thus giving flexibility as to when to take a blood sample.”
BackgroundDurber, S. M., Lawson, J. P., & Daly, J. R. (1976) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1976.tb00750.x · Cited by 22
Factors Affecting Dexamethasone Suppression Test Results
Berlińska, A., Świątkowska-Stodulska, R., & Sworczak, K. (2019) · Experimental and clinical endocrinology & diabetes · doi:10.1055/a-1017-3217 · Cited by 14
Welsch, C. W., de Iturri, G. C., & Brennan, M. J. (1976) · Cancer · doi:10.1002/1097-0142(197609)38:3 · Cited by 41
Self-citationEffects of Gonadal and Contraceptive Hormones on Protein and Amino Acid Metabolism
Seal, U. S., & DOE, R. P. (1969) · Springer eBooks · doi:10.1007/978-1-4684-1782-1_21 · Cited by 21
Self-citationFotherby, K., Trayner, I., Longthorne, P. N., Lee, B., & Watson, H. R. (1987) · Contraception · doi:10.1016/0010-7824(87)90069-2 · Cited by 19
Formation, Metabolism, and Transport of Estrogen Conjugates
Diczfalusy, E. R., & Levitz, M. (1970) · Springer eBooks · doi:10.1007/978-3-642-95177-0_6 · Cited by 22
Geisler, J., Haynes, B. P., Anker, G. B., Helle, H., Ekse, D., Dowsett, M., & Lønning, P. E. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.05.004 · Cited by 18
Serum Proteins in Prostatic Cancer. I. Relationship between Clinical Stage and Level
Ablin, R. J., Gonder, M. J., & Soanes, W. A. (1973) · The Journal of Urology · doi:10.1016/s0022-5347(17)60175-7 · Cited by 17
Serum lipid changes after estrogen therapy in prostatic carcinoma
Bulusu, N. V., Lewis, S. B., Das, S. P., et al. (1982) · Urology · doi:10.1016/0090-4295(82)90345-4 · Cited by 16
Formation, Metabolism, and Transport of Estrogen Conjugates
Diczfalusy, E. R., & Levitz, M. (1970) · Springer eBooks · doi:10.1007/978-3-642-49793-3_6 · Cited by 16
Fritjofsson, Å., Norlén, B. J., Högberg, B., et al. (1981) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365598109181211 · Cited by 16
The Pathology of the Human Placenta
Benirschke, K., & Driscoll, S. G. (1967) · Springer eBooks · doi:10.1007/978-3-662-38455-8_2 · Cited by 15
ESTROGENIC MANAGEMENT OF BENIGN PROSTATISM, INCLUDING EARLY AND POOR‐RISK CASES: 7‐YEAR EXPERIENCE*
Roberts, H. J. (1966) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1966.tb02895.x · Cited by 15
Corticosteroid-binding globulin and estrogens in maternal and cord blood
Wilson, E. A., Finn, A. E., Rayburn, W. F., & Jawad, M. (1979) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(79)90346-6 · Cited by 14
KINETIC STUDIES OF CORTISOL AND SYNTHETIC CORTICOSTEROIDS IN MAN
Fell, P. J. (1972) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1972.tb00378.x · Cited by 14
Mondorf, A. W., Mackenrodt, G., & Halberstadt, E. (1971) · Journal of Molecular Medicine · doi:10.1007/bf01497302 · Cited by 14
EFFECT OF CYPROTERONE ACETATE‐ETHINYL OESTRADIOL TREATMENT ON ADRENAL FUNCTION IN HIRSUTE WOMEN
CHAPMAN, M. G., And, S. L. J., & Dewhurst, C. J. (1982) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1982.tb01630.x · Cited by 14
FACTORS INFLUENCING THE RATE OF METABOLISM OF STEROID HORMONES IN MAN
LIPSETT, M. B. (1971) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1971.tb46921.x · Cited by 14
Prostatic cancer Transcortin levels during treatment with estramustine phosphate
Sandberg, A. A., Rosenthal, H. E., Mittelman, A., et al. (1975) · Urology · doi:10.1016/0090-4295(75)90585-3 · Cited by 13
Drug Control of Steroid Metabolism by the Hepatic Endoplasmic Reticulum
Feuer, G. M. (1983) · Drug Metabolism Reviews · doi:10.3109/03602538308991424 · Cited by 13
CAWOOD, M. L., Heys, R. F., & OAKEY, R. E. (1976) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1976.tb01963.x · Cited by 13
Bäcklund, N., Lundstedt, S., Tornevi, A., Wihlbäck, A.-C., Olsson, T., Dahlqvist, P., & Brattsand, G. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad763 · Cited by 13
“CBG induction has been reported to be dependent on the estrogen dose and not to be influenced by the synthetic progestin component of the COC (6, 18).”
BackgroundBaumann, G. P. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-6-1193 · Cited by 11
BERTOLISSI, CARTEI, TURRIN, et al. (1998) · Cytopathology · doi:10.1046/j.1365-2303.1998.00077.x · Cited by 11
Pharmacology of natural and synthetic estrogens
Fotherby, K. (1976) · Springer eBooks · doi:10.1007/978-94-011-6165-7_7 · Cited by 11
ORAL CONTRACEPTIVES AND GLUCOSE TOLERANCE
Doar, J. W. H., & Wynn, V. (1969) · The Lancet · doi:10.1016/s0140-6736(69)91678-x · Cited by 11
Edwards, P. D., & Boonstra, R. (2015) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2015.11.004 · Cited by 10
BERGINK, E. W., Crona, N., Dahlgren, E., & Samsioe, G. (1981) · Maturitas · doi:10.1016/0378-5122(81)90031-1 · Cited by 10
Saleh, F. M. (1977) · Contraception · doi:10.1016/0010-7824(77)90051-8 · Cited by 9
Silveira‐Rosa, T., Mateus‐Pinheiro, A., Correia, J. S., Silva, J. M., Martins‐Macedo, J., Araújo, B., Machado-Santos, A. R., Alves, N. D., da Silva, M. R., Loureiro‐Campos, E., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.13165 · Cited by 7
Effect of estrogen administration upon ceruloplasmin and copper concentrations in rat serum
Sunderman, F. W., Nomoto, S., Gillies, C. G., et al. (1971) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(71)90264-x · Cited by 7
A quantitative analysis of serum proteins during treatment with oral contraceptive steroids
Settlage, D. S. F., Nakamura, R. M., Davajan, V., et al. (1970) · Contraception · doi:10.1016/0010-7824(70)90050-8 · Cited by 7
Current Status of Estrogen Therapy for Prostatic Carcinoma
Blackard, C. E., & Mellinger, G. T. (1972) · Postgraduate Medicine · doi:10.1080/00325481.1972.11698173 · Cited by 7
Models of Adrenal Cortical Control
Gann, D. S., & Cryer, G. L. (1972) · Elsevier eBooks · doi:10.1016/b978-0-12-004902-8.50006-5 · Cited by 6
Current concepts in the management of carcinoma of the prostate gland.
Meares, E. M. (1972) · PubMed · Cited by 6
Oestrogen Therapy and Serum Cortisol in Carcinoma of the Prostate
Morales, Á., Kraus, A. S., & Bruce, A. W. (1975) · British Journal of Urology · doi:10.1111/j.1464-410x.1975.tb03966.x · Cited by 4
Schwartz, U., & Hammerstein, J. (1975) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1975.13.7.291 · Cited by 4
Pharmacology of estrogens—general
Dorfman, R. I. (1980) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(80)90018-2 · Cited by 3
Bonnin, M., Martin, B., Charron, G., Audy, M. C., & Canivenc, R. (1984) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(84)90126-2 · Cited by 3
KAWAGOE, S., & HIROI, M. (1978) · Folia Endocrinologica Japonica · doi:10.1507/endocrine1927.54.5_666 · Cited by 3
Kawagoe, S., & Hiroi, M. (1978) · Folia Endocrinologica Japonica · doi:10.1507/endocrine1927.54.1_1 · Cited by 3
Oral Contraceptive Use by Teenage Women Does Not Affect Body Composition
Lloyd, T., Lin, H. M., Matthews, A. E., et al. (2002) · Obstetrics and Gynecology · doi:10.1097/00006250-200208000-00006 · Cited by 3
Animal models of hormonal contraceptives: Understanding drug‐specific and user‐specific variables
Lacasse, J. M., Ismail, N., Porcu, P., & Raval, A. P. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.13500 · Cited by 4
The Incidence of Cardiovascular Complications in Prostatic Cancer
Mellinger, G. T., & Blackard, C. E. (1971) · Elsevier eBooks · doi:10.1016/b978-0-08-017572-0.50009-8 · Cited by 2
Wilson, E. A., Jawad, M., & Donaldson, E. S. (1981) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(81)90480-4 · Cited by 2
Adrenocortical Function of Patients Using Oral Contraceptives
Kauppila, A., Järvinen, P. A., Ylöstalo, P., et al. (1974) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016347409156906 · Cited by 2
Estrogen Receptor in the Mammalian Liver: Developmental and Metabolic Aspects
Eisenfeld, A. J., & Aten, R. F. (1980) · Elsevier eBooks · doi:10.1016/b978-0-08-024940-7.50011-1 · Cited by 2
Serum proteins in patients with benign prostatic hyperplasia
Marczyńska, A., Adamczyk, B., & Lenko, J. (1983) · International Urology and Nephrology · doi:10.1007/bf02082102 · Cited by 1
“In the overall endocrine alterations, which generate or accompany the development of hyperplasia, the role of intraglandular processes and humoral immune reactions has to be emphasized [4, 16 ].”
BackgroundDetermination of Estrone, 17B-Estradiol and Estriol in Urine of Young Adults
Lee, S.-F. (2021) · Digital Commons - USU (Utah State University) · doi:10.26076/7e50-cafe · Cited by 1
Wright, J. D., & Sadovsky, Y. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-787-1_19 · Cited by 1
Benirschke, K., & Driscoll, S. G. (1967) · Springer eBooks · doi:10.1007/978-1-4612-9809-0_15 · Cited by 3
Strauss, F., Benirschke, K., & Driscoll, S. G. (1967) · Springer eBooks · doi:10.1007/978-3-662-25615-2_15 · Cited by 1
Miller, J. F., Fotherby, K., Bye, P., et al. (1979) · Contraception · doi:10.1016/0010-7824(79)90039-8 · Cited by 1
Immunological Effects of Diethylstilbestrol in the Human
Kalland, T., & Hofman, R. (1987) · Springer eBooks · doi:10.1007/978-94-009-4307-0_26 · Cited by 1
Ebeling, H. (1975) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1975.13.10.445 · Cited by 1
Farmaci interferenti sul trasporto del cortisolo
Santeusanio, F., & Falorni, A. (2008) · L Endocrinologo · doi:10.1007/bf03344611
Effect of hormone therapy on immune response in patients with prostatic cancer
Guinan, P., Ablin, R. J., Nourkayhan, S., et al. (1975) · Urology · doi:10.1016/0090-4295(75)90797-9
Measurement of Biomarkers for Environmental Estrogen Exposure in Raccoons
Dean-Colomb, W. M., & Jeffery, E. H. (1999) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Metadata
- Authors
- MUSA, B. U., SEAL, U. S., DOE, R. P., Lamusga, R. F., Lewis, M. D., & Glaser, R.
- Affiliations
- University of Minnesota (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1965-09
- Volume
- 25
- Issue
- 9
- Pages
- 1163-1166
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2059773854
- Cited by
- 105
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2021: 3 · 2019: 2 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 1 · 2012: 2
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
- Keywords
- estrogen, corticosteroid-binding globulin, beta-glucuronidase, ceruloplasmin, dose-response relationship, conjugated equine estrogens, diethylstilbestrol, ethinyl estradiol, sex differences, estrogen potency
- MeSH terms
- Adult, Blood, Ceruloplasmin, Diethylstilbestrol, Estrogens, Conjugated (USP), Ethinyl Estradiol, Glucuronidase, Humans, Male, Transcortin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review